Diurnal to raise £10m
A Welsh pharmaceutical company has revealed plans to raise approximately £10m to help it continue to develop a new product. Insider Media reports Diurnal Group, who listed on AIM, will look to secure £8m through a conditional placing and a further £2m through an open offer. Cardiff based Diurnal is a specialty pharmaceutical company dedicated … Continue reading Diurnal to raise £10m
Diurnal hails year of progress
The chief executive of listed business Diurnal has said the company’s latest financial year marked a key transition in progress towards its vision of “becoming a world-leading endocrinology specialty pharma company” after increasing its commercial footprint in key marketplaces. Insider Media reports in the year to June 30th 2020 total revenues rose from £1m to … Continue reading Diurnal hails year of progress
Diurnal proposes £1m share placing
Speciality pharmaceutical company Diurnal, which is headquartered in Cardiff, has revealed plans to raise £1m to aid the commercialisation of products. Insider Media reports this follows a conditional placing which raised £5.35m before expenses. Martin Whitaker, chief executive of Diurnal, said “Diurnal has continued to make strong progress across its business, including the successful launch … Continue reading Diurnal proposes £1m share placing
